N
Neko Health
Preventive full-body health scans with proprietary sensors and clinician review
About Neko Health
Neko Health is a Stockholm-founded preventive health company that builds clinics and proprietary scanning hardware for a roughly 60-minute, non-invasive full-body assessment—combining skin imaging, biomarkers and blood analysis with an on-site clinician consultation. Co-founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, Neko operates clinics across Sweden and the UK (including multiple London sites plus Manchester and Birmingham), has registered more than 350,000 people for a scan and completed over 100,000 member scans, and is preparing US expansion starting in New York. In July 2026 Neko raised a $700 million Series C led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum and BDT & MSD, following a $260 million Series B in January 2025; proceeds fund US clinics, further clinic rollout and continued in-house hardware and health-data platform development. Sources: Tech.eu, 15 Jul 2026; Neko Health press; TechCrunch.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Stockholm, Sweden
- Employees
- 680
- Open positions
- 134
- Dealroom signal
- 95.7/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, MRI, Medical Imaging, Core AI, Precision Medicine, Non-Invasive medical devices and treatments, Health Diagnostics
- Technology
- Artificial Intelligence, Hardware, Deep Tech
- Client focus
- b2b, b2c
Knowledge graph
News
Neko Health raises $700M Series C at ~$7bn valuation
Jul 15, 2026
News
Neko Health taps ~1.7B SEK debt to fund its global scan rollout
Jul 10, 2026
News
Neko Health raises 265M SEK as it opens New York clinic
Jul 3, 2026
Market map
600+ Global VC backed Precision Medicine startups
Market map
Healthy ageing (silver health, elderly care, longevity) Europe
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE | Jul 2026 | $206M | — | Undisclosed | ↗ |
| SERIES C | Jul 2026 | $700M | $7B | Atomico · General Catalyst · Positive Sum · O.G. Venture Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Neko Health is 410K monthly website visits, up 10.8% over the last three months. Neko Health's team grew 73% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Atomico
Lakestar
Prima Materia
General Catalyst
Lightspeed Venture Partners
Rasello
O.G. Venture Partners
Atomic
Series B and later3 investors entered at this stage
Positive Sum
Liberty City Ventures
BDT & MSD Partners
Other known investors3 additional known investors
Alexandre Momeni- KKKim Kok
Paul Kwan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neko Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neko Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.